%0 Journal Article
%A Macak, Dominik
%A Lee, Shin-Yu
%A Nyman, Tomas
%A Ampah-Korsah, Henry
%A Strandback, Emilia
%A Pääbo, Svante
%A Zeberg, Hugo
%+ Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society
Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society
Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society
%T Muscle AMP deaminase activity was lower in Neandertals than in modern humans : 
%G eng
%U https://hdl.handle.net/21.11116/0000-0011-7EB1-8
%R 10.1038/s41467-025-61605-4
%7 2025-07-10
%D 2025
%8 10.07.2025
%* Review method: peer-reviewed
%X The enzyme AMPD1 is expressed in skeletal muscle and is involved in ATP production. All available Neandertal genomes carry a lysine-to-isoleucine substitution at position 287 in AMPD1. This variant, which occurs at an allele frequency of 0–8% outside Africa, was introduced to modern humans by gene flow from Neandertals. Here, we show that the catalytic activity of the purified Neandertal AMPD1 is ~25% lower than the ancestral enzyme, and when introduced in mice, it reduces AMPD activity in muscle extracts by ~80%. Among present-day Europeans, another AMPD1 variant encoding a stop codon occurs at an allele frequency of 9–14%. Individuals heterozygous for this variant are less likely to be top-performing athletes in various sports, but otherwise reduced AMPD1 activity is well tolerated in present-day humans. While being conserved among vertebrates, AMPD1 seems to have become less functionally important among Neandertals and modern humans.
%K Enzymes, Evolutionary biology, Evolutionary genetics, Metabolism

%J Nature Communications
%V 16
%] 6371
%@ 2041-1723